Search Results - F. Castagnetti

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    P701: COVID-19 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN TREATMENT-FREE REMISSION: DISEASE SEVERITY AND IMPACT ON TFR STATUS by S. Saußele, N. Evans, F. E. Nicolini, E. Chelysheva, D. Réa, F. Castagnetti, S. Claudiani, R. Rodrigues, C. Kok, T. Hughes

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  2. 2

    S152: SETD2/H3K36ME3 DEFICIENCY SUSTAINS GENOMIC INSTABILITY AND ENHANCES CLONOGENIC POTENTIAL OF CHRONIC MYELOID LEUKEMIA (CML) PROGENITORS by M. Mancini, S. De Santis, C. Monaldi, S. Bruno, F. Castagnetti, G. Gugliotta, A. Iurlo, M. Cerrano, S. Galimberti, S. Balducci, F. Stagno, G. Rosti, M. Cavo, S. Soverini

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  3. 3

    DP124 | CHARACTERISTICS, OUTCOMES AND MUTATIONAL ANALYSIS OF CHRONIC MYELOID LEUKEMIA PATIENTS RECEIVING ASCIMINIB IN BOLOGNA by M. Iezza, S. Cortesi, R. Restuccia, E. Ottaviani, C. Venturi, M. Mancini, C. Monaldi, S. De Santis, V. Bagnis, N. Testoni, S. Soverini, P.L. Zinzani, F. Castagnetti

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  4. 4

    P218 | QUANTIFICATION OF ATYPICAL BCR::ABL1 TRANSCRIPTS BY DIGITAL PCR: A EUTOS PROJECT by A.C. Danzero, E. Gottardi, D. Cilloni, J. Petiti, R. Vacca, A. Ferrando, S. Grano, V. Bonuomo, F. Castagnetti, M.C. Miggiano, S. Galimberti, F. Muriano, G. Saglio, A. Hochhaus, T. Ernst, C. Fava

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  5. 5

    C067 | SETD2 DEFICIENCY IN CHRONIC MYELOID LEUKEMIA DRIVES METABOLIC REPROGRAMMING PROMOTING TYROSINE KINASE INHIBITOR RESISTANCE AND DISEASE PROGRESSION by M. Mancini, L. Romagnoli, S. De Santis, C. Monaldi, S. Bruno, C. Mosca, A. Merlotti, D. Remondini, E. Esposito, J. Fiori, F. Castagnetti, M. Iezza, R. Restuccia, V. Bagnis, A. Iurlo, M. Cerrano, S. Galimberti

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  6. 6

    DP131 | TREATMENT-FREE REMISSION AFTER PONATINIB: AN ITALIAN CAMPUS CML EXPERIENCE by C. Fava, G. Rosti, S. Grano, M. Dalmazzo, V. Bonuomo, M. Santoro, D. Cattaneo, M. Caramella, E. Abruzzese, F. Castagnetti, V. Giai, C. Elena, M.C. Miggiano, L. Levato, M. Tiribelli, G. Loglisci, F. Lunghi, U. Markovic, A. Savi, M. Breccia, G. Saglio

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  7. 7

    P1706: CLINICAL UTILITY OF ONLINE MONITORING OF PATIENT-REPORTED SYMPTOMS IN NEWLY DIAGNOSED PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN REAL-LIFE PRACTICE by F. Efficace, F. Cottone, B. Yanez, F. Castagnetti, G. Caocci, M. Bonifacio, A. Patriarca, I. Capodanno, M. C. Miggiano, M. Tiribelli, M. Breccia, L. Luciano, V. Giai, A. Iurlo, E. Abruzzese, C. Fava, G. Rosti, J. Cortes, V. Kota, M. Vignetti, D. Cella

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  8. 8

    S156: INTERNATIONAL, PROSPECTIVE STUDY COMPARING NILOTINIB VERSUS IMATINIB WITH EARLY SWITCH TO NILOTINIB TO OBTAIN SUSTAINED TREATMENT-FREE REMISSION IN PATIENTS WITH WITH CHRONIC... by F. Pane, F. Castagnetti, L. Luciano, A. Russo Rossi, E. Abruzzese, R. Bassan, G. Binotto, G. Caocci, G. Cimino, P. Fazi, A. Gozzini, M. Lunghi, R. Marasca, B. Martino, M. Bonifacio, F. Cavazzini, F. Paoloni, G. Saglio, S. Sica, A. Tafuri, D. Vallisa, M. Vignetti, P. Westerweel, G. Rosti, M. Breccia

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  9. 9

    P712: ASCIMINIB ITALIAN MANAGED ACCESS PROGRAM: EFFICACY PROFILE IN HEAVILY PRE-TREATED CML PATIENTS by M. Breccia, A. V. Russo Rossi, B. Martino, E. Abruzzese, M. Annunziata, G. Binotto, A. Ermacora, C. Fava, L. Giaccone, V. Giai, A. P. Nardozza, P. Coco, A. Gozzini, L. Levato, A. Lucchesi, L. Luciano, M. Maria Cristina, G. Rege-Cambrin, M. Santoro, B. Scappini, A. R. Scortechini, P. Sportoletti, E. Trabacchi, F. Castagnetti

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  10. 10

    C069 | SECOND ATTEMPT TO DISCONTINUE TKI AFTER MOLECULAR RELAPSE IN CHRONIC MYELOID LEUKEMIA PATIENTS: A REAL-LIFE ITALIAN MULTICENTER STUDY by A. Iurlo, D. Cattaneo, C. Fava, F. Castagnetti, M. Bonifacio, M. C. Miggiano, M. D’adda, I. Capodanno, C. Elena, L. Levato, A. R. Scortechini, F. Lunghi, M. Caramella, V. Bellani, V. Bonuomo, S. Grano, G. Cotilli, E. Scalzulli, M. Dalmazzo, S. Leonetti Crescenzi, L. Luciano, B. Martino, T. Intermesoli, D. Rapezzi, G. Binotto, M. Tiribelli, G. Saglio, C. Gambacorti-Passerini, M. Breccia, G. Rosti

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  11. 11

    P698: BOSUTINIB DOSE OPTIMIZATION IN THE SECOND-LINE TREATMENT OF ELDERLY CML PATIENTS: EXTENDED 3-YEAR FOLLOW-UP AND FINAL RESULTS OF THE BEST STUDY by F. Castagnetti, M. Bocchia, E. Abruzzese, I. Capodanno, M. Bonifacio, G. Rege Cambrin, M. Crugnola, G. Binotto, C. Elena, A. Lucchesi, M. Bergamaschi, F. Albano, L. Luciano, F. Sorà, F. Lunghi, F. Stagno, M. Cerrano, A. Iurlo, A. R. Scortechini, S. Leonetti Crescenzi, R. Spadano, E. Trabacchi, M. Lunghi, G. Spinosa, D. Ferrero, D. Rapezzi, M. Ladetto, L. Nocilli, G. Gugliotta, M. Iezza, M. Cavo, G. Saglio, F. Pane, G. Rosti

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  12. 12

    Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study by A. Iurlo, D. Cattaneo, D. Cattaneo, D. Consonni, F. Castagnetti, M. C. Miggiano, G. Binotto, M. Bonifacio, G. Rege-Cambrin, M. Tiribelli, F. Lunghi, A. Gozzini, P. Pregno, E. Abruzzese, I. Capodanno, C. Bucelli, M. Pizzuti, S. Artuso, M. Iezza, E. Scalzulli, G. La Barba, A. Maggi, S. Russo, C. Elena, A. R. Scortechini, A. Tafuri, R. Latagliata, G. Caocci, M. Bocchia, S. Galimberti, L. Luciano, C. Fava, R. Foà, G. Saglio, G. Rosti, M. Breccia

    Published in Frontiers in Pharmacology (2023-03-01)
    Get full text
    Article


Search Tools: